Literature DB >> 25402579

Methods of rapid diagnosis for the etiology of meningitis in adults.

Nathan C Bahr1, David R Boulware.   

Abstract

Infectious meningitis may be due to bacterial, mycobacterial, fungal or viral agents. Diagnosis of meningitis must take into account numerous items of patient history and symptomatology along with regional epidemiology and basic cerebrospinal fluid testing (protein, etc.) to allow the clinician to stratify the likelihood of etiology possibilities and rationally select additional diagnostic tests. Culture is the mainstay for diagnosis in many cases, but technology is evolving to provide more rapid, reliable diagnosis. The cryptococcal antigen lateral flow assay (Immuno-Mycologics) has revolutionized diagnosis of cryptococcosis and automated nucleic acid amplification assays hold promise for improving diagnosis of bacterial and mycobacterial meningitis. This review will focus on a holistic approach to diagnosis of meningitis as well as recent technological advances.

Entities:  

Keywords:  Cryptococcus meningitis; aseptic meningitis; bacterial meningitis; diagnosis; diagnostic tests; tuberculosis meningitis

Mesh:

Year:  2014        PMID: 25402579      PMCID: PMC4239990          DOI: 10.2217/bmm.14.67

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  115 in total

Review 1.  Acute community-acquired bacterial meningitis in adults: an evidence-based review.

Authors:  Adarsh Bhimraj
Journal:  Cleve Clin J Med       Date:  2012-06       Impact factor: 2.321

2.  Bacterial meningitis in adults after splenectomy and hyposplenic states.

Authors:  Kirsten S Adriani; Matthijs C Brouwer; Arie van der Ende; Diederik van de Beek
Journal:  Mayo Clin Proc       Date:  2013-04-28       Impact factor: 7.616

3.  Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting.

Authors:  Suzaan Marais; Dominique J Pepper; Charlotte Schutz; Robert J Wilkinson; Graeme Meintjes
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

Review 4.  Aseptic meningitis.

Authors:  Bonita E Lee; H Dele Davies
Journal:  Curr Opin Infect Dis       Date:  2007-06       Impact factor: 4.915

5.  Community-acquired bacterial meningitis in cirrhotic patients.

Authors:  C Cabellos; P F Viladrich; J Ariza; J-M Maiques; R Verdaguer; F Gudiol
Journal:  Clin Microbiol Infect       Date:  2007-11-13       Impact factor: 8.067

6.  Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.

Authors:  W E Dismukes; G Cloud; H A Gallis; T M Kerkering; G Medoff; P C Craven; L G Kaplowitz; J F Fisher; C R Gregg; C A Bowles; S Shadomy; A M Stamm; R B Diasio; L Kaufman; S Soong; W C Blackwelder
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

7.  Tuberculous meningitis: a uniform case definition for use in clinical research.

Authors:  Suzaan Marais; Guy Thwaites; Johan F Schoeman; M Estée Török; Usha K Misra; Kameshwar Prasad; Peter R Donald; Robert J Wilkinson; Ben J Marais
Journal:  Lancet Infect Dis       Date:  2010-09-06       Impact factor: 25.071

8.  Central nervous system immune reconstitution inflammatory syndrome.

Authors:  Nathan Bahr; David R Boulware; Suzaan Marais; James Scriven; Robert J Wilkinson; Graeme Meintjes
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

9.  Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis.

Authors:  Mark D Lindsley; Nanthawan Mekha; Henry C Baggett; Yupha Surinthong; Rinrapas Autthateinchai; Pongpun Sawatwong; Julie R Harris; Benjamin J Park; Tom Chiller; S Arunmozhi Balajee; Natteewan Poonwan
Journal:  Clin Infect Dis       Date:  2011-08       Impact factor: 9.079

10.  Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Authors:  D M Daugla; J P Gami; K Gamougam; N Naibei; L Mbainadji; M Narbé; J Toralta; B Kodbesse; C Ngadoua; M E Coldiron; F Fermon; A-L Page; M H Djingarey; S Hugonnet; O B Harrison; L S Rebbetts; Y Tekletsion; E R Watkins; D Hill; D A Caugant; D Chandramohan; M Hassan-King; O Manigart; M Nascimento; A Woukeu; C Trotter; J M Stuart; McJ Maiden; B M Greenwood
Journal:  Lancet       Date:  2013-09-12       Impact factor: 79.321

View more
  32 in total

1.  A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis.

Authors:  Nathan C Bahr; Lillian Tugume; David R Boulware
Journal:  J Clin Microbiol       Date:  2016-01       Impact factor: 5.948

2.  Illuminating meningococcal diagnosis with LAMP.

Authors:  Nathan C Bahr; David R Boulware
Journal:  Lancet Infect Dis       Date:  2015-02-27       Impact factor: 25.071

3.  Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia.

Authors:  Omar K Siddiqi; Gretchen L Birbeck; Musie Ghebremichael; Eugene Mubanga; Shawn Love; Clayton Buback; Barry Kosloff; Helen Ayles; Masharip Atadzhanov; Keertan Dheda; Igor J Koralnik
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

4.  Is it possible to differentiate tuberculous and cryptococcal meningitis in HIV-infected patients using only clinical and basic cerebrospinal fluid characteristics?

Authors:  J E Vidal; E J F Peixoto de Miranda; J Gerhardt; M Croda; D R Boulware
Journal:  S Afr Med J       Date:  2017-01-30

5.  Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis.

Authors:  Nathan C Bahr; Graeme Meintjes; David R Boulware
Journal:  J Med Microbiol       Date:  2019-04-17       Impact factor: 2.472

Review 6.  Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.

Authors:  Betty A Forbes; Geraldine S Hall; Melissa B Miller; Susan M Novak; Marie-Claire Rowlinson; Max Salfinger; Akos Somoskövi; David M Warshauer; Michael L Wilson
Journal:  Clin Microbiol Rev       Date:  2018-01-31       Impact factor: 26.132

Review 7.  State-of-the-Art Microbiologic Testing for Community-Acquired Meningitis and Encephalitis.

Authors:  Christopher R Polage; Stuart H Cohen
Journal:  J Clin Microbiol       Date:  2016-02-17       Impact factor: 5.948

8.  Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF.

Authors:  N C Bahr; L Tugume; R Rajasingham; R Kiggundu; D A Williams; B Morawski; D Alland; D B Meya; J Rhein; D R Boulware
Journal:  Int J Tuberc Lung Dis       Date:  2015-10       Impact factor: 2.373

9.  Comparative Diagnostic Utility of IS6110 PCR Assay in CSF and Peripheral Blood Samples of Tuberculous Meningitis Patients: A Pilot Study from Central India.

Authors:  Sonali D Manke; Aliabbas A Husain; Hatim F Daginawala; Lokendra K Singh; Rajpal S Kashyap
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 10.  Diagnostic Testing of Neurologic Infections.

Authors:  Prashanth S Ramachandran; Michael R Wilson
Journal:  Neurol Clin       Date:  2018-11       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.